Osborn Williams & Donohoe LLC lowered its position in shares of Stryker Corporation (NYSE:SYK) by 1.4% during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 84,022 shares of the medical technology company’s stock after selling 1,155 shares during the period. Stryker Corporation accounts for about 2.1% of Osborn Williams & Donohoe LLC’s investment portfolio, making the stock its 5th largest position. Osborn Williams & Donohoe LLC’s holdings in Stryker Corporation were worth $11,661,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also recently modified their holdings of the company. Bourne Lent Asset Management Inc. purchased a new position in shares of Stryker Corporation during the second quarter worth $208,000. BB&T Corp increased its position in shares of Stryker Corporation by 5.7% in the second quarter. BB&T Corp now owns 56,546 shares of the medical technology company’s stock worth $7,847,000 after buying an additional 3,060 shares during the last quarter. Bollard Group LLC increased its position in shares of Stryker Corporation by 0.4% in the second quarter. Bollard Group LLC now owns 832 shares of the medical technology company’s stock worth $115,000 after buying an additional 3 shares during the last quarter. State Treasurer State of Michigan increased its position in shares of Stryker Corporation by 221.5% in the second quarter. State Treasurer State of Michigan now owns 326,996 shares of the medical technology company’s stock worth $45,381,000 after buying an additional 225,300 shares during the last quarter. Finally, BTIM Corp. increased its position in shares of Stryker Corporation by 1.2% in the second quarter. BTIM Corp. now owns 428,253 shares of the medical technology company’s stock worth $59,433,000 after buying an additional 4,985 shares during the last quarter. Hedge funds and other institutional investors own 74.07% of the company’s stock.

Stryker Corporation (SYK) traded up 0.11% during mid-day trading on Friday, hitting $146.53. 638,405 shares of the stock traded hands. The stock has a 50-day moving average price of $142.76 and a 200-day moving average price of $134.44. Stryker Corporation has a 12 month low of $106.48 and a 12 month high of $148.84. The stock has a market cap of $54.81 billion, a P/E ratio of 32.71 and a beta of 0.80.

Stryker Corporation (NYSE:SYK) last issued its quarterly earnings data on Thursday, July 27th. The medical technology company reported $1.53 EPS for the quarter, topping the consensus estimate of $1.51 by $0.02. Stryker Corporation had a net margin of 14.22% and a return on equity of 24.26%. The firm had revenue of $3.01 billion for the quarter, compared to analyst estimates of $2.98 billion. During the same period in the prior year, the business posted $1.39 EPS. The business’s revenue for the quarter was up 6.1% compared to the same quarter last year. On average, equities analysts forecast that Stryker Corporation will post $6.50 earnings per share for the current year.

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, October 31st. Stockholders of record on Friday, September 29th will be issued a $0.425 dividend. The ex-dividend date is Thursday, September 28th. This represents a $1.70 annualized dividend and a dividend yield of 1.16%. Stryker Corporation’s dividend payout ratio is currently 37.95%.

WARNING: “Stryker Corporation (SYK) Position Lowered by Osborn Williams & Donohoe LLC” was originally published by Daily Political and is the property of of Daily Political. If you are accessing this article on another domain, it was illegally stolen and republished in violation of U.S. & international copyright and trademark law. The correct version of this article can be accessed at https://www.dailypolitical.com/2017/08/05/stryker-corporation-syk-position-lowered-by-osborn-williams-donohoe-llc.html.

A number of research analysts recently commented on SYK shares. Morgan Stanley increased their price target on shares of Stryker Corporation from $145.00 to $155.00 and gave the company an “overweight” rating in a report on Wednesday, June 21st. Needham & Company LLC reaffirmed a “sell” rating on shares of Stryker Corporation in a report on Wednesday, April 26th. Jefferies Group LLC reaffirmed a “hold” rating and issued a $132.00 price target on shares of Stryker Corporation in a report on Thursday, April 13th. Cantor Fitzgerald started coverage on shares of Stryker Corporation in a report on Thursday, June 29th. They issued a “neutral” rating and a $153.00 price target for the company. Finally, BidaskClub downgraded shares of Stryker Corporation from a “strong-buy” rating to a “buy” rating in a report on Tuesday, June 13th. Three equities research analysts have rated the stock with a sell rating, seven have given a hold rating and twelve have assigned a buy rating to the company. The company presently has an average rating of “Hold” and a consensus price target of $144.03.

In other news, insider David Floyd sold 19,305 shares of the company’s stock in a transaction that occurred on Wednesday, July 12th. The shares were sold at an average price of $144.56, for a total value of $2,790,730.80. The sale was disclosed in a document filed with the SEC, which is available through this link. Corporate insiders own 7.40% of the company’s stock.

About Stryker Corporation

Stryker Corporation is a medical technology company. The Company offers a range of medical technologies, including orthopedic, medical and surgical, and neurotechnology and spine products. The Company’s segments include Orthopaedics; MedSurg; Neurotechnology and Spine, and Corporate and Other. The Orthopaedics segment includes reconstructive (hip and knee) and trauma implant systems and other related products.

Institutional Ownership by Quarter for Stryker Corporation (NYSE:SYK)

Receive News & Ratings for Stryker Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stryker Corporation and related companies with MarketBeat.com's FREE daily email newsletter.